{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:17:09Z","timestamp":1782123429215,"version":"3.54.5"},"reference-count":120,"publisher":"Tech Science Press","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":151,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.062142","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:55:31Z","timestamp":1742360131000},"page":"1255-1270","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Recent advances in understanding the role of sex hormone receptors in urothelial cancer"],"prefix":"10.32604","volume":"33","author":[{"given":"MOHAMMAD AMIN","family":"ELAHI NAJAFI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKUO","family":"MATSUKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROSHI","family":"MIYAMOTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA A Cancer J Clinicians"},{"key":"ref2","first-page":"229","article-title":"Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"ref3","unstructured":"SEER Cancer Stat Facts: Bladder Cancer, National Cancer Institute; [accessed 2024 Dec 9]. Available from: http:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14737140.2020.1744437","article-title":"Why has the prognosis for muscle-invasive bladder cancer not significantly improved after decades of therapeutic advancements?","volume":"20","author":"Goto","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/cancers15030566","article-title":"Current and future landscape of perioperative treatment for muscle-invasive bladder cancer","volume":"15","author":"Esteban-Villarrubia","year":"2023","journal-title":"Cancers"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cncr.23986","article-title":"Sex and racial differences in bladder cancer presentation and mortality in the US","volume":"115","author":"Scosyrev","year":"2009","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2017.06.021","article-title":"Role of the androgen receptor in urothelial cancer","volume":"465","author":"Inoue","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"643870","DOI":"10.3389\/fendo.2021.643870","article-title":"The role of estrogen receptors in urothelial cancer","volume":"12","author":"Goto","year":"2021","journal-title":"Front Endocrinol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/cells10051169","article-title":"Sex hormone receptor signaling in bladder cancer: a potential target for enhancing the efficacy of conventional non-surgical therapy","volume":"10","author":"Ide","year":"2021","journal-title":"Cells"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e0174746","DOI":"10.1371\/journal.pone.0174746","article-title":"Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: a meta-analysis of immunohistochemical studies","volume":"12","author":"Ide","year":"2017","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.21037\/tcr.2020.01.06","article-title":"The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma","volume":"9","author":"Nagata","year":"2020","journal-title":"Transl Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.urolonc.2009.01.033","article-title":"Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression","volume":"29","author":"Tuygun","year":"2011","journal-title":"Urol Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5114\/pjp.2018.79543","article-title":"The prognostic significance of androgen receptor and \u03b2-catenin immunohistochemical expression in urothelial carcinoma with and without detrusor muscle invasion from an Egyptian institution","volume":"69","author":"Elzamy","year":"2018","journal-title":"Pol J Pathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/iju.13841","article-title":"Distribution of androgen receptor expression in the urinary bladder","volume":"26","author":"Yasui","year":"2019","journal-title":"Int J Urol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tranon.2019.01.005","article-title":"Androgen receptor mRNA expression in urothelial carcinoma of the bladder: a retrospective analysis of two independent cohorts","volume":"12","author":"Sikic","year":"2019","journal-title":"Transl Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/life11070642","article-title":"High androgen receptor mRNA expression is associated with improved outcome in patients with high-risk non-muscle-invasive bladder cancer","volume":"11","author":"Sikic","year":"2021","journal-title":"Life"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s12253-018-0431-7","article-title":"Androgen receptor predicts first and multiple recurrences in non-muscle invasive urothelial carcinoma of the bladder","volume":"25","author":"Yonekura","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"ref19","first-page":"325","article-title":"Implications of androgen receptor and FUS expression on tumor progression in urothelial carcinoma","volume":"36","author":"Abd Raboh","year":"2021","journal-title":"Histol Histopathol"},{"key":"ref20","first-page":"11514","article-title":"Immunohistochemical expression of androgen receptors in urothelial carcinoma of urinary bladder. Is it significant? Experience from coastal India","volume":"95","author":"Jindal","year":"2023","journal-title":"Arch Ital Urol Androl"},{"key":"ref21","first-page":"485","article-title":"Cytoplasmic androgen receptor, CD24 expression and smoking intensity to urothelial carcinoma of the bladder invasiveness: a cross-sectional study","volume":"15","author":"Pramod","year":"2023","journal-title":"Res Rep Urol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"15795","DOI":"10.1007\/s00432-023-05348-z","article-title":"Correlation between androgen and estrogen receptor expression and clinicopathologic features in carcinoma urinary bladder","volume":"149","author":"Shrivastava","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1309\/QPHDRB00QXGMUQ9N","article-title":"Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma","volume":"120","author":"Goldstein","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"15840","DOI":"10.1038\/ncomms15840","article-title":"Insufficient antibody validation challenges oestrogen receptor beta research","volume":"8","author":"Andersson","year":"2017","journal-title":"Nat Commun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mce.2016.11.016","article-title":"Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity","volume":"440","author":"Nelson","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/jpm11060473","article-title":"ESR1 and ERBB2 expression can predict pathologic outcome in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer","volume":"11","author":"J\u00fctte","year":"2021","journal-title":"J Pers Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"63.e9","DOI":"10.1016\/j.urolonc.2021.06.021","article-title":"High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer","volume":"40","author":"Sikic","year":"2022","journal-title":"Urol Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"738.e23","DOI":"10.1016\/j.urolonc.2020.04.022","article-title":"Estrogen receptors in urogenital schistosomiasis and bladder cancer: estrogen receptor alpha-mediated cell proliferation","volume":"38","author":"Bernardo","year":"2020","journal-title":"Urol Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"589649","DOI":"10.3389\/pore.2021.589649","article-title":"Clinicopathological significance of estrogen receptor \u03b2 and estrogen synthesizing\/metabolizing enzymes in urothelial carcinoma of urinary bladder","volume":"27","author":"Sato","year":"2021","journal-title":"Pathol Oncol Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/jnci\/djk113","article-title":"Promotion of bladder cancer development and progression by androgen receptor signals","volume":"99","author":"Miyamoto","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.ajpath.2013.01.018","article-title":"Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor","volume":"182","author":"Hsu","year":"2013","journal-title":"Am J Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e0148851","DOI":"10.1371\/journal.pone.0148851","article-title":"Conditional expression of the androgen receptor increases susceptibility of bladder cancer in mice","volume":"11","author":"Johnson","year":"2016","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000474484","article-title":"Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats","volume":"31","author":"Imada","year":"1997","journal-title":"Eur Urol"},{"key":"ref34","first-page":"461","article-title":"GATA3 in the urinary bladder: Suppression of neoplastic transformation and down-regulation by androgens","volume":"4","author":"Li","year":"2014","journal-title":"Am J Cancer Res"},{"key":"ref35","first-page":"2041","article-title":"Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis","volume":"7","author":"Kawahara","year":"2017","journal-title":"Am J Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"14710","DOI":"10.18632\/oncotarget.3817","article-title":"Secondary bladder cancer after anticancer therapy for prostate cancer: Reduced comorbidity after androgen-deprivation therapy","volume":"6","author":"Shiota","year":"2015","journal-title":"Oncotarget"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.18632\/oncotarget.2851","article-title":"Androgen deprivation therapy prevents bladder cancer recurrence","volume":"5","author":"Izumi","year":"2014","journal-title":"Oncotarget"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.18632\/oncotarget.7358","article-title":"Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence","volume":"7","author":"Izumi","year":"2016","journal-title":"Oncotarget"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.juro.2016.08.006","article-title":"Suppressed recurrent bladder cancer after androgen suppression with androgen deprivation therapy or 5\u03b1-reductase inhibitor","volume":"197","author":"Shiota","year":"2017","journal-title":"J Urol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eururo.2015.08.029","article-title":"Finasteride reduces risk of bladder cancer in a large prospective screening study","volume":"69","author":"Morales","year":"2016","journal-title":"Eur Urol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"E3588","DOI":"10.1073\/pnas.1113960109","article-title":"CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated","volume":"109","author":"Overdevest","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mc.21833","article-title":"Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: A potential mechanism of androgen-induced bladder carcinogenesis","volume":"52","author":"Izumi","year":"2013","journal-title":"Mol Carcinog"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1530\/EC-18-0364","article-title":"ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling","volume":"7","author":"Inoue","year":"2018","journal-title":"Endocr Connect"},{"key":"ref44","first-page":"2325","article-title":"ELK1 promotes urothelial tumorigenesis in the presence of an activated androgen receptor","volume":"8","author":"Inoue","year":"2018","journal-title":"Am J Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1535-7163.MCT-17-0786","article-title":"Nuclear factor-\u03baB promotes urothelial tumorigenesis and cancer progression via cooperation with androgen receptor signaling","volume":"17","author":"Inoue","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.23736\/S2724-6051.19.03563-X","article-title":"Possible role of 5-alpha reductase inhibitors in non-invasive bladder urothelial neoplasm: Multicenter study","volume":"74","author":"Pastore","year":"2022","journal-title":"Minerva Urol Nephrol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"12881","DOI":"10.1038\/s41598-023-34646-2","article-title":"Relationship between testosterone and male bladder cancer","volume":"13","author":"Tan","year":"2023","journal-title":"Sci Rep"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/BLC-200380","volume":"6","author":"Nagata","year":"2020","journal-title":"Bladder Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"15827","DOI":"10.1073\/pnas.0505554102","article-title":"A fully dissociated compound of plant origin for inflammatory gene repression","volume":"102","author":"De Bosscher","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","first-page":"1779","article-title":"Compound A inhibits urothelial tumorigenesis via both the androgen receptor and glucocorticoid receptor signaling pathways","volume":"12","author":"Ide","year":"2020","journal-title":"Am J Transl Res"},{"key":"ref51","first-page":"4386","volume":"10","author":"Nagata","year":"2020","journal-title":"Am J Cancer Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/ERC-20-0004","article-title":"FOXO1 as a tumor suppressor inactivated via AR\/ER\u03b2 signals in urothelial cells","volume":"27","author":"Ide","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/mc.23783","article-title":"Latrophilin-3 as a downstream effector of the androgen receptor induces urothelial tumorigenesis","volume":"63","author":"Goto","year":"2024","journal-title":"Mol Carcinog"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1593\/tlo.13247","article-title":"Chemoprevention of BBN-induced bladder carcinogenesis by the selective estrogen receptor modulator tamoxifen","volume":"6","author":"George","year":"2013","journal-title":"Transl Oncol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1158\/0008-5472.CAN-05-3530","volume":"66","author":"Waalkes","year":"2006","journal-title":"Cancer Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.18632\/oncotarget.1421","volume":"5","author":"Hsu","year":"2014","journal-title":"Oncotarget"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/carcin\/bgt348","article-title":"Suppression of ER\u03b2 signaling via ER\u03b2 knockout or antagonist protects against bladder cancer development","volume":"35","author":"Hsu","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/mc.21978","article-title":"Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen","volume":"53","author":"Izumi","year":"2014","journal-title":"Mol Carcinog"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eururo.2022.09.030","article-title":"FGFR3 mutational activation can induce luminal-like papillary bladder tumor formation and favors a male sex bias","volume":"83","author":"Shi","year":"2023","journal-title":"Eur Urol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/ERC-11-0010","article-title":"Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells","volume":"18","author":"Zheng","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/ERC-12-0328","article-title":"Androgen activates \u03b2-catenin signaling in bladder cancer cells","volume":"20","author":"Li","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"29860","DOI":"10.18632\/oncotarget.5007","article-title":"ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression","volume":"6","author":"Kawahara","year":"2015","journal-title":"Oncotarget"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.canlet.2014.03.018","article-title":"Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition","volume":"348","author":"Jing","year":"2014","journal-title":"Cancer Lett"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"432.e15","DOI":"10.1016\/j.urolonc.2016.05.016","article-title":"Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth","volume":"34","author":"Kawahara","year":"2016","journal-title":"Urol Oncol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2490-8-7","article-title":"Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: A role for thrombospondin-1","volume":"8","author":"Johnson","year":"2008","journal-title":"BMC Urol"},{"key":"ref66","first-page":"578","article-title":"Androgen receptor (AR) promotes male bladder cancer cell proliferation and migration via regulating CD24 and VEGF","volume":"8","author":"Ding","year":"2016","journal-title":"Am J Transl Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12672-024-01324-2","article-title":"Latrophilin-3 as a downstream effector of the androgen receptor induces bladder cancer progression","volume":"15","author":"Goto","year":"2024","journal-title":"Discov Oncol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.canlet.2019.12.018","volume":"473","author":"Yang","year":"2020","journal-title":"Cancer Lett"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41418-021-00743-w","article-title":"Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR\/circRNA-ARC1\/miR-125b-2-3p or miR-4736\/PPAR\u03b3\/MMP-9 signals","volume":"28","author":"Deng","year":"2021","journal-title":"Cell Death Differ"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"e48467","DOI":"10.15252\/embr.201948467","article-title":"Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion","volume":"21","author":"Chen","year":"2020","journal-title":"EMBO Rep"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-20-3095","article-title":"Androgen receptor regulates CD44 expression in bladder cancer","volume":"81","author":"Sottnik","year":"2021","journal-title":"Cancer Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"109490","DOI":"10.1016\/j.biopha.2019.109490","article-title":"Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer","volume":"120","author":"Quan","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"620306","DOI":"10.3389\/fonc.2020.620306","article-title":"A novel androgen-induced lncRNA FAM83H-AS1 promotes prostate cancer progression via the miR-15a\/CCNE2 axis","volume":"10","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12967-023-03972-4","article-title":"Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer","volume":"21","author":"Seok","year":"2023","journal-title":"J Transl Med"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41419-023-05882-1","article-title":"Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK\/JUP signalling","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41388-019-0964-6","article-title":"Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated G\u03b1i protein\/MAPK\/MMP9 intracellular signaling","volume":"39","author":"Chen","year":"2020","journal-title":"Oncogene"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2021.01.029","article-title":"Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis","volume":"504","author":"Katleba","year":"2021","journal-title":"Cancer Lett"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41598-023-28692-z","article-title":"Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells","volume":"13","author":"Katleba","year":"2023","journal-title":"Sci Rep"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.urology.2007.02.041","article-title":"Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma","volume":"69","author":"Sonpavde","year":"2007","journal-title":"Urology"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/erc.1.01255","article-title":"Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation","volume":"15","author":"Teng","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12672-012-0123-9","article-title":"Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation","volume":"4","author":"Hoffman","year":"2013","journal-title":"Horm Cancer"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.18632\/oncotarget.5467","article-title":"Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ER\u03b2\/CCL2\/CCR2 EMT\/MMP9 signals","volume":"7","author":"Rao","year":"2016","journal-title":"Oncotarget"},{"key":"ref83","first-page":"1146","volume":"5","author":"Yeh","year":"2015","journal-title":"Am J Cancer Res"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.canlet.2018.03.045","article-title":"Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor \u03b2\/IL-1\/c-MET signals","volume":"430","author":"Tao","year":"2018","journal-title":"Cancer Lett"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41419-019-1581-6","article-title":"Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1\/ER\u03b2\/Bcl-2 signalling","volume":"10","author":"Long","year":"2019","journal-title":"Cell Death Dis"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/geno.1998.5095","article-title":"Discovery of three novel G-protein-coupled receptor genes","volume":"47","author":"O\u2019Dowd","year":"1998","journal-title":"Genomics"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1210\/en.2007-1669","article-title":"The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation","volume":"149","author":"Teng","year":"2008","journal-title":"Endocrinology"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/1568009622666220413084456","article-title":"PBX1 participates in estrogen-mediated bladder cancer progression and chemo-resistance affecting estrogen receptors","volume":"22","author":"Zhao","year":"2022","journal-title":"Curr Cancer Drug Targets"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/ijc.32036","article-title":"miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer","volume":"144","author":"Ge","year":"2019","journal-title":"Int J Cancer"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41419-019-1827-3","article-title":"ER\u03b1-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion","volume":"10","author":"Wu","year":"2019","journal-title":"Cell Death Dis"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0155-5","article-title":"Estrogen receptor \u03b2 promotes bladder cancer growth and invasion via alteration of miR-92a\/DAB2IP signals","volume":"50","author":"Ou","year":"2018","journal-title":"Exp Mol Med"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"13841","DOI":"10.1002\/jcb.28657","article-title":"The enhanced expression of estrogen-related receptor \u03b1 in human bladder cancer tissues and the effects of estrogen-related receptor \u03b1 knockdown on bladder cancer cells","volume":"120","author":"Ye","year":"2019","journal-title":"J Cell Biochem"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1158\/1535-7163.MCT-14-1055-T","article-title":"Antiandrogen therapy with hydroxyflutamide or androgen receptor degradation enhancer ASC-J9 enhances BCG efficacy to better suppress bladder cancer progression","volume":"14","author":"Shang","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.juro.2012.02.2554","article-title":"Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer","volume":"188","author":"Shiota","year":"2012","journal-title":"J Urol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"49169","DOI":"10.18632\/oncotarget.9994","article-title":"Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer","volume":"7","author":"Kashiwagi","year":"2016","journal-title":"Oncotarget"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3892\/ijo.2016.3781","article-title":"Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression","volume":"50","author":"Kameyama","year":"2017","journal-title":"Int J Oncol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13046-019-1258-0","volume":"38","author":"Huang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/1535-7163.MCT-17-1061","article-title":"Androgen receptor signaling reduces radiosensitivity in bladder cancer","volume":"17","author":"Ide","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"ref99","first-page":"2959","article-title":"Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation","volume":"5","author":"Kawahara","year":"2015","journal-title":"Am J Cancer Res"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euros.2022.06.007","article-title":"Combining antiandrogens with immunotherapy for bladder cancer treatment","volume":"43","author":"Besan\u00e7on","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1158\/1535-7163.MCT-20-0050","volume":"19","author":"Mizushima","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.urolonc.2019.03.008","article-title":"Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder","volume":"37","author":"Tyagi","year":"2019","journal-title":"Urol Oncol"},{"key":"ref103","first-page":"3111","article-title":"Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer","volume":"41","author":"Sekino","year":"2019","journal-title":"Oncol Rep"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"13733","DOI":"10.3390\/ijms241813733","article-title":"GABBR2 as a downstream effector of the androgen receptor induces cisplatin resistance in bladder cancer","volume":"24","author":"Elahi Najafi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1111\/cas.14557","article-title":"FOXO1 inactivation induces cisplatin resistance in bladder cancer","volume":"111","author":"Ide","year":"2020","journal-title":"Cancer Sci"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/cancers13050975","article-title":"Identification of BXDC2 as a key downstream effector of the androgen receptor in modulating cisplatin sensitivity in bladder cancer","volume":"13","author":"Jiang","year":"2021","journal-title":"Cancer"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"10030","DOI":"10.3390\/ijms221810030","article-title":"Androgen receptor signaling induces cisplatin resistance via down-regulating GULP1 expression in bladder cancer","volume":"22","author":"Teramoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"110840","DOI":"10.1016\/j.cbi.2023.110840","article-title":"Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine\/cisplatin resistance in bladder cancer","volume":"388","author":"Himura","year":"2024","journal-title":"Chem Biol Interact"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/j.clgc.2017.09.016","article-title":"Association of androgen receptor expression on tumor cells and PD-L1 expression in muscle-invasive and metastatic urothelial carcinoma: Insights for clinical research","volume":"16","author":"Necchi","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.21873\/cgp.20435","article-title":"Association of androgen receptor and PD-L1 expression in upper urinary tract urothelial carcinoma","volume":"21","author":"Okuda","year":"2024","journal-title":"Cancer Geno Proteom"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"100148","DOI":"10.1016\/j.labinv.2023.100148","article-title":"Androgen receptor transcriptionally inhibits programmed death ligand-1 expression and influences immune escape in bladder cancer","volume":"103","author":"Sun","year":"2023","journal-title":"Lab Invest"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00345-020-03358-x","article-title":"Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival","volume":"39","author":"Toren","year":"2021","journal-title":"World J Urol"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/s41417-022-00506-w","article-title":"Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2\/circ_0001005\/PD-L1 signaling","volume":"29","author":"Liu","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-5347(01)67119-2","article-title":"Tamoxifen enhances the chemosensitivity of bladder carcinoma cells","volume":"41","author":"Pu","year":"1995","journal-title":"J Urol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1464-410X.1996.82712.x","article-title":"Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy","volume":"77","author":"Pu","year":"1996","journal-title":"Br J Urol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.3892\/or.2015.4220","article-title":"Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells","volume":"34","author":"Takeuchi","year":"2015","journal-title":"Oncol Rep"},{"key":"ref117","first-page":"2523","article-title":"Estrogen receptor-\u03b2 signaling induces cisplatin resistance in bladder cancer","volume":"10","author":"Goto","year":"2020","journal-title":"Am J Cancer Res"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"557","DOI":"10.21873\/cgp.20472","article-title":"GULP1 as a downstream effector of the estrogen receptor-\u03b2 modulates cisplatin sensitivity in bladder cancer","volume":"21","author":"Tatenuma","year":"2024","journal-title":"Cancer Genom Proteom"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1080\/15384047.2016.1235667","article-title":"Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract","volume":"17","author":"Kashiwagi","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1200\/JCO.2019.37.7_suppl.471","article-title":"Results from a phase I\/Ib trial of enzalutamide and gemcitabine and cisplatin in metastatic bladder cancer (mBC)","volume":"37","author":"Gupta","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-6\/OncolRes-33-06-62142\/OncolRes-33-62142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:35:02Z","timestamp":1763343302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n6\/61348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":120,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.062142","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"2024-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-29","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}